NYSE:VNEVeoneer Stock Price, Forecast & News

Veoneer's stock was trading at $8.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VNE shares have increased by 26.5% and is now trading at $11.37. View which stocks have been most impacted by Coronavirus.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Veoneer.

Veoneer is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Veoneer.

Veoneer Inc (NYSE:VNE) released its quarterly earnings results on Friday, April, 24th. The company reported ($1.49) earnings per share for the quarter, missing the consensus estimate of ($1.34) by $0.15. The firm had revenue of $362 million for the quarter, compared to the consensus estimate of $359 million. Veoneer had a negative return on equity of 29.08% and a negative net margin of 33.63%. View Veoneer's earnings history.

Veoneer issued an update on its first quarter 2020 Pre-Market earnings guidance on Friday, March, 20th. The company provided EPS guidance of for the period. The company issued revenue guidance of $350-370 million, compared to the consensus revenue estimate of $390.09 million.

9 brokers have issued 1-year target prices for Veoneer's shares. Their forecasts range from $9.00 to $26.00. On average, they anticipate Veoneer's share price to reach $15.38 in the next twelve months. This suggests a possible upside of 35.2% from the stock's current price. View analysts' price targets for Veoneer.

Media stories about VNE stock have trended very negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Veoneer earned a daily sentiment score of -3.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news aboutVeoneer.

Some companies that are related to Veoneer include Allison Transmission (ALSN), LCI Industries (LCII), Dorman Products (DORM), Dana (DAN), Adient (ADNT), Meritor (MTOR), Gentherm (THRM), Delphi Technologies (DLPH), American Axle & Manufact. (AXL), Standard Motor Products (SMP), Tower International (TOWR), Stoneridge (SRI), IOCHPE MAXION S/S (IOCJY), Tenneco (TEN) and Garrett Motion (GTX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Pfizer (PFE), Autoliv (ALV), Franklin Resources (BEN), Canadian Natural Resources (CNQ), Constellation Pharmaceuticals (CNST), California Resources (CRC), Dominion Energy (D), Delta Air Lines (DAL), Enterprise Products Partners (EPD) and Gilead Sciences (GILD).

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (1.92%), DNB Asset Management AS (1.59%), State Street Corp (0.37%), Invesco Ltd. (0.31%), JPMorgan Chase & Co. (0.29%) and Swiss National Bank (0.18%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View institutional ownership trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Two Sigma Investments LP, Bank of New York Mellon Corp, Engineers Gate Manager LP, Tudor Investment Corp Et Al, Victory Capital Management Inc., Victory Capital Management Inc., and Formidable Asset Management LLC. View insider buying and selling activity for Veoneer.

VNE stock was purchased by a variety of institutional investors in the last quarter, including DNB Asset Management AS, JPMorgan Chase & Co., Invesco Ltd., Jane Street Group LLC, State Street Corp, Aigen Investment Management LP, FNY Investment Advisers LLC, and GSA Capital Partners LLP. Company insiders that have bought Veoneer stock in the last two years include Arthur Blanchford, Jan Carlson, Mathias Hermansson, and Mikko S Taipale. View insider buying and selling activity for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $11.37.

Veoneer has a market capitalization of $1.27 billion and generates $1.90 billion in revenue each year. The company earns $-500,000,000.00 in net income (profit) each year or ($4.92) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.

The official website for Veoneer is www.veoneer.com.

Veoneer's mailing address is 26545 AMERICAN DRIVE, SOUTHFIELD MI, 48034. The company can be reached via phone at 248-223-0600 or via email at [email protected]